20.12.2017
- At a Dec. 19 meeting with Prime Minister Benjamin Netanyahu and high-ranking cabinet ministers, management of Teva Pharmaceuticals, the world’s largest generic drugmaker and Israel...
15.12.2017
- As had been widely expected, Israel-headquartered Teva Pharmaceuticals – world’s largest generics producer – announced on Dec. 14 it would slash 14,000 jobs, about a quarter of its...
04.12.2017
- Kåre Schultz, new chief executive officer of debt-plagued Israeli drugmaker Teva, is moving rapidly to make good on his pledge to improve the company’s financial performance and...
22.09.2017
- Israeli generics giant Teva has completed its exit from the women’s health sector. On Sept. 18 it unloaded its contraception, fertility, menopause and osteoporosis products to CVC...
13.09.2017
- After a protracted search, Israeli generics giant Teva has appointed a new president and chief executive officer. Kåre Schultz will take over from interim CEO Yitzhak Peterburg at...
31.08.2017
- Three weeks after announcing it would cut 350 jobs at two plants in Israel, generics producer Teva has trimmed the number back to 285. The company said it will only eliminate 65...
08.08.2017
- As its financial woes continue to deepen, Israeli generics producer Teva is making plans to lay off 7,000 employees and close 15 plants. CEO Yitzhak Peterburg said the company will...
20.07.2017
- The European Commission has accused Israeli drugmaker Teva and its US subsidiary Cephalon of breaching antitrust rules. Regulators classed an agreement between the companies to...
